Anzeige
Mehr »
Samstag, 26.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2H5F4 | ISIN: FI4000252127 | Ticker-Symbol: 4TS
Frankfurt
25.07.25 | 09:08
10,700 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
TERVEYSTALO OYJ Chart 1 Jahr
5-Tage-Chart
TERVEYSTALO OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
10,66010,86013:02
GlobeNewswire (Europe)
58 Leser
Artikel bewerten:
(0)

Medhelp Care AB: MedHelp has entered into a strategic agreement with Terveystalo Healthcare, conditional upon completion of the public offer announced earlier today for the shares in MedHelp

MedHelp Care Aktiebolag (publ) ("MedHelp" or the "Company") has today entered into a strategic cooperation agreement with Terveystalo Healthcare Oy ("Terveystalo Healthcare"), a wholly-owned indirect subsidiary of Terveystalo Plc ("Terveystalo"), conditional upon the completion of the public offer for all shares in the Company announced earlier today (the "Offer") (the "Agreement").

Terveystalo is Finland's largest private healthcare provider in terms of revenue and one of the leading providers of occupational healthcare services in Finland and Sweden with approximately 15,000 employees. Terveystalo offers comprehensive primary care, specialist care, and health services for companies, private individuals and public sector customers.

Medhelp and Terveystalo Healthcare have agreed to establish a partnership with the aim that MedHelp's platform will be sold by Terveystalo in Finland, complementing Terveystalo's digital occupational health offering. The partnership also involves joint development of new products and functions.

The initial term of the agreement will be 6 years with an automatic extension of 3 years if the agreement is not terminated. The yearly license fee will amount to SEK 8.8 million and Terveystalo guarantees, under certain conditions, MedHelp annual recurring revenues (ARR) of up to SEK 21.2 million (2026) rising to SEK 42.2 million (2031). These guaranteed revenues primarily consist of recurring payments based on the number of connected employees on MedHelp's platform and depending on that number the revenues may be higher than what is guaranteed.

"We are very proud that, through this partnership, our platform will now be accessible to a significantly large number of companies on the Finnish market. The collaboration with Terveystalo also gives us increased resources and capacity to continue developing our digital solutions, which are already at the forefront. Today, our solutions assist more than 500 clients in Sweden and Denmark in reducing sick leave, responding more quickly to early signs of illness, and building sustainable, healthy workplaces for the long term," says Tobias Ekros, CEO of MedHelp.

The Agreement is conditional upon the completion of the Offer, and neither MedHelp's nor Terveystalo Healthcare's obligations under the Agreement shall enter into force unless and until the Offer has been completed. The Company's assessment is that the conclusion of the Agreement is not to be considered an offer-related arrangement under section II.17a of the Takeover Rules for certain trading platforms.

For further information, please contact:
Tobias Ekros, CEO
tobias.ekros@medhelpcare.com
Phone: 08 528 528 00

About MedHelp Care
MedHelp Care offers a Health Platform that is used by more than 500 companies and organizations in the systematic health work and management of sick leave and rehabilitation. Using AI and health data, MedHelp Care identifies early signs of ill health and helps managers and HR to work proactively with preventive measures. MedHelp Care is listed on Nasdaq First North.

For more information, see MedHelp Care's website www.medhelp.se.

The Company's Certified Adviser is DNB Carnegie.

This information is information that MedHelp Care AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-07-25 07:55 CEST.

© 2025 GlobeNewswire (Europe)
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.